A Study to Assess Multidomain Endpoints of an ECG Patch

Trial Identifier:	D1840M00072
Sponsor:	AstraZeneca
Start Date:	January 2024
Primary Completion Date:	February 2026
Study Completion Date:	February 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
GB	Cambridge, GB, CB2 0QQ
GB	Harefield, GB, UB9 6JH
GB	Leicester, GB, LE3 9PQ

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.